<DOC>
	<DOCNO>NCT01170884</DOCNO>
	<brief_summary>Comparing Safety Efficacy Combigan® Lumigan® Lumigan® Alone Glaucoma Ocular Hypertension Subjects Treated Xalatan® .</brief_summary>
	<brief_title>Comparing Safety Efficacy Combigan® Lumigan® With Lumigan® Alone Glaucoma Ocular Hypertension Subjects Treated With Xalatan®</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<mesh_term>Brimonidine Tartrate</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Brimonidine Tartrate , Timolol Maleate Drug Combination</mesh_term>
	<mesh_term>Maleic acid</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<criteria>Diagnosed glaucoma ocular hypertension . Visual Acuity 20/100 well eye Any active ocular disease History intraocular surgery glaucoma laser surgery within 3 month Contraindication pupil dilation Use topical , periorbital , intravitreal , systemic steroid within 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
</DOC>